Results 171 to 180 of about 653,218 (240)

Synergic Efficacy of a Multicomponent Nutraceutical Add-On Therapy in Seasonal Allergic Rhinitis in Children: A Prospective, Randomized, Parallel-Group Study. [PDF]

J Clin Med
Gori A, Brindisi G, Anania C, Spalice A, Zicari AM.   +4 more
europepmc   +1 more source

Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. <i>J. Clin. Med.</i> 2025, <i>14</i>, 2609. [PDF]

J Clin Med
Gerstlauer M, Hiller J, Raab J, Birkholz K, Tapparo M, Neuhof C, Day L, Rybachuk A, Acikel C, Sahin H, Hebbeler K, Becker S, Vogelberg C, Allekotte S, Kramer MF, The Tapas Study Group.   +15 more
europepmc   +1 more source

Self-management and information needs of adults with seasonal allergic rhinitis in the Netherlands: A focus group study. [PDF]

J Health Psychol
Mulder BC, Kasteleyn MJ, Hall L, van Vliet AJ, de Weger LA.   +4 more
europepmc   +1 more source

Modulation of Cellular, Molecular, and Humoral Responses by PQ Grass 27,600 SU for the Treatment of Seasonal Allergic Rhinitis: A Randomised Double Blind Placebo Control Exploratory Field Study. [PDF]

Allergy
Layhadi JA, Starchenka S, De Kam PJ, Palmer E, Wu LYD, Keane ST, Fulton WT, Hikmawati P, Meng X, Filipaviciute P, Cutrina Pons A, Oluwayi K, Lis K, Armfield O, Skinner MA, Heath MD, Hewings SJ, Kramer MF, Shamji MH.   +18 more
europepmc   +1 more source

Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study. [PDF]

Asia Pac Allergy
Wang M, Zhang Y, Li J, Wang C, Zhang L.
europepmc   +1 more source

Effect of heat-killed <i>Lacticaseibacillus paracasei</i> KW3110 on mild to moderate seasonal allergic rhinitis symptoms in Japanese adults: a randomized, double-blind, placebo-controlled parallel-group study. [PDF]

Front Nutr
Sugihara Y, Zheng J, Fukushima Y, Nozawa H, Ushida Y, Tsuji R, Okamoto Y, Fujiwara D.   +7 more
europepmc   +1 more source

LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial. [PDF]

Clin Transl Allergy
Guan K, Liu S, Feng Y, Li L, Zhu X, Bill NC, Ma H, Yang J, Han C, Liu H, Wei Q, Shi H, Wang X.   +12 more
europepmc   +1 more source

Inverse association between the molecular spreading of IgE to grass pollen and the IgE response to Dermatophagoides pteronyssinus among children with seasonal allergic rhinitis. [PDF]

World Allergy Organ J
Brindisi G, Cipriani F, Potapova E, Tripodi S, Panetta V, Bernardini R, Caffarelli C, Casani A, Cervone R, Chini L, Comberiati P, Castro G, Del Giudice MM, Iacono ID, Businco ADR, Dramburg S, Gallucci M, Giannetti A, Moschese V, Sfika I, Varin E, Ricci G, Reese G, Zicari AM, Matricardi PM.   +24 more
europepmc   +1 more source

Probiotics combined with prebiotics alleviated seasonal allergic rhinitis by altering the composition and metabolic function of intestinal microbiota: a prospective, randomized, double-blind, placebo-controlled clinical trial. [PDF]

Front Immunol
Hou Y, Wang D, Zhou S, Huo C, Chen H, Li F, Ding M, Li H, Zhao H, He J, Da H, Ma Y, Qiang Z, Chen X, Bai C, Cui J, Gao N, Liu Y.   +17 more
europepmc   +1 more source

Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial. [PDF]

EClinicalMedicine
Zhang Y, Yan B, Zhu Z, Wang X, Song X, Zhu D, Ma T, Zhang Y, Meng C, Wang G, Wang C, Zhang L.   +11 more
europepmc   +1 more source